Gastroesophageal Junction Cancer Overview

Save information for later
Sign Up

Learn About Gastroesophageal Junction Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Gastroesophageal Junction Cancer Local Doctors?
Hope E. Uronis
Elite in Gastroesophageal Junction Cancer
Elite in Gastroesophageal Junction Cancer

Duke Cancer Center

20 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Hope Uronis is an Oncologist in Durham, North Carolina. Dr. Uronis is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. Her top areas of expertise are Gastroesophageal Junction Cancer, Colorectal Cancer, Pancreatic Cancer, Stomach Cancer, and Pancreaticoduodenectomy. Dr. Uronis is currently accepting new patients.

Howard P. Safran
Elite in Gastroesophageal Junction Cancer
Hematology Oncology | Hematology | Oncology
Elite in Gastroesophageal Junction Cancer
Hematology Oncology | Hematology | Oncology

Rhode Island Hospital

593 Eddy St, 
Providence, RI 
Languages Spoken:
English
Offers Telehealth

Howard Safran is a Hematologist Oncology specialist and a Hematologist in Providence, Rhode Island. Dr. Safran is rated as an Elite provider by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Pancreatic Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, Stomach Cancer, and Pancreaticoduodenectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Eric Van Cutsem
Elite in Gastroesophageal Junction Cancer
Elite in Gastroesophageal Junction Cancer
Leuven, VLG, BE 

Eric Van Cutsem practices in Leuven, Belgium. Mr. Van Cutsem is rated as an Elite expert by MediFind in the treatment of Gastroesophageal Junction Cancer. His top areas of expertise are Colorectal Cancer, Gastroesophageal Junction Cancer, Stomach Cancer, Hepato-Pancreato-Biliary Surgery, and Endoscopy.

What are the latest Gastroesophageal Junction Cancer Clinical Trials?
Iparomlimab and Tuvonralimab Injection Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC) That Progresses From First-line PD-1 Combined Chemotherapy, A Prospective, Single-arm, Phase II Clinical Study

Summary: This study is a single-arm study aimed at evaluating the efficacy and safety of Iparomlimab and Tuvonralimab Injection combined with apatinib and irinotecan hydrochloride in the treatment of advanced alpha-fetoprotein gastric cancer (AFPGC) that progresses from first-line PD-1 combined with chemotherapy. The study enrolled patients with advanced gastric cancer and gastroesophageal junction cancer ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase I/II Open-label Dose Escalation and Dose Expansion Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of AZD4360 in Adult Participants With Advanced Solid Tumours

Summary: The purpose of this study is to evaluate the safety, tolerability, PK, immunogenicity, pharmacodynamics, and preliminary efficacy of AZD4360 in adult participants with locally advanced or metastatic solid tumours selected for expression of CLDN18.2.